Selective killing of adriamycin-resistant (G2 checkpoint-deficient and MRP1-expressing) cancer cells by docetaxel.

Source:http://linkedlifedata.com/resource/pubmed/id/15899832

Cancer Res. 2005 May 15 65 10 4401-7

Download in:

View as

Triples

General Info

PMID
15899832